Telomir Pharmaceuticals Says Preclinical Drug Candidate Prevents Premature Aging In Patient-Derived Cells From Children With Progeria

benzinga.com/news/health-care/25/06/45994523/exclusive-telomir-pharmaceuticals-says-preclinical-drug-candidate-prevents-premature-aging-in-pa

Telomir Pharmaceuticals Inc. (NASDAQ:TELO) on Wednesday announced new preclinical data showing that its lead candidate, Telomir-1, prevented cellular aging in human progeria cell lines obtained from the Progeria Research Foundation.
In this study, conducted by Smart Assays, Telomir-1 was…

This story appeared on benzinga.com, 2025-06-18 13:00:25.
The Entire Business World on a Single Page. Free to Use →